211 related articles for article (PubMed ID: 7999824)
1. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms.
Gagnon RF; Richards GK; Kostiner GB
Adv Perit Dial; 1994; 10():189-92. PubMed ID: 7999824
[TBL] [Abstract][Full Text] [Related]
2. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
Richards GK; Morcos RJ; Gagnon RF
Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
[TBL] [Abstract][Full Text] [Related]
3. Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms.
Richards GK; Gagnon RF; Prentis J
ASAIO Trans; 1991; 37(3):M160-2. PubMed ID: 1751091
[TBL] [Abstract][Full Text] [Related]
4. The modulation by fresh and spent peritoneal dialysis fluids of antibiotic kinetics directed against Staphylococcus epidermidis biofilms.
Richards GK; Kostiner GB; Gagnon RF
Adv Perit Dial; 1992; 8():246-9. PubMed ID: 1361798
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms.
Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP
J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin.
Gagnon RF; Richards GK; Wiesenfeld L
ASAIO Trans; 1991; 37(3):M158-60. PubMed ID: 1751090
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections.
Arciola CR; Campoccia D; Gamberini S; Donati ME; Pirini V; Visai L; Speziale P; Montanaro L
Biomaterials; 2005 Nov; 26(33):6530-5. PubMed ID: 15949842
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic activity against Staphylococcus epidermidis biofilms in dialysis fluids.
Richards GK; Prentis J; Gagnon RF
Adv Perit Dial; 1989; 5():133-7. PubMed ID: 2577396
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP
Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690
[TBL] [Abstract][Full Text] [Related]
10. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
11. Impact of dialysis fluid on the susceptibility of Staphylococcus epidermidis biofilms to rifampin.
Gagnon RF; Richards GK; Kostiner GB; Morcos R
Adv Perit Dial; 1993; 9():183-6. PubMed ID: 8105919
[TBL] [Abstract][Full Text] [Related]
12. The effects of heparin on rifampin activity against Staphylococcus epidermidis biofilms.
Gagnon RF; Harris AD; Prentis J; Richards GK
Adv Perit Dial; 1989; 5():138-42. PubMed ID: 2577397
[TBL] [Abstract][Full Text] [Related]
13. Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis.
Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D
Med Microbiol Immunol; 2002 Oct; 191(2):107-14. PubMed ID: 12410350
[TBL] [Abstract][Full Text] [Related]
14. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
15. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
Lee JY; Ko KS; Peck KR; Oh WS; Song JH
J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
[TBL] [Abstract][Full Text] [Related]
17. Rifampin activity against Staphylococcus epidermidis biofilms.
Obst G; Gagnon RF; Prentis J; Richards GK
ASAIO Trans; 1988; 34(3):782-4. PubMed ID: 3196598
[TBL] [Abstract][Full Text] [Related]
18. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Singh R; Ray P; Das A; Sharma M
Microsc Res Tech; 2010 Jul; 73(7):662-4. PubMed ID: 20572203
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
[TBL] [Abstract][Full Text] [Related]
20. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
